Physician

Alexander Barsouk, MD

According to 2025 Medicare claims, Alexander Barsouk, MD (NPI: 1114929544) practices hematology/oncology, with the plurality of this provider's patient population coming from Clarion, PA. This provider's primary affiliated billing organization is BUTLER MEDICAL PROVIDERS (NPI: 1639788102; TIN: 25-1441961) and primary practice location at 16214-8501. Barsouk is affiliated with the Bridges Health Partners Accountable Care Organization (ACO ID: A3919), participating under the MSSP model.

Barsouk's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 301 traditional Medicare patients, billed 559 HCPCS/CPT codes, and received $37,896 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,499 prescription claims across 220 beneficiaries totaling $4,859,253 in drug costs, led by Jakafi (Ruxolitinib Phosphate). DME data shows 117 claims. Open Payments data shows 210 records totaling $122,729. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $49,313 to $37,896. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,262,194 to $4,859,253. For DME billing, this smaller-volume category did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$41K$81K2015 Medicare payment: $49,313 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $63,029 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $81,310 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $63,811 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $56,240 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $39,921 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $45,779 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $42,056 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $37,333 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $37,896 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015270648$49,313
20162811,005$63,029
20172621,445$81,310
20182571,693$63,811
20194311,751$56,240
2020373608$39,921
2021385606$45,779
2022358590$42,056
2023310533$37,333
2024301559$37,896

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.4M$4.9M2015 Drug cost: $1,262,194 (USD; Tot_Drug_Cst)2016 Drug cost: $1,228,537 (USD; Tot_Drug_Cst)2017 Drug cost: $1,580,594 (USD; Tot_Drug_Cst)2018 Drug cost: $2,114,356 (USD; Tot_Drug_Cst)2019 Drug cost: $3,054,462 (USD; Tot_Drug_Cst)2020 Drug cost: $3,273,865 (USD; Tot_Drug_Cst)2021 Drug cost: $2,576,276 (USD; Tot_Drug_Cst)2022 Drug cost: $3,786,295 (USD; Tot_Drug_Cst)2023 Drug cost: $3,871,223 (USD; Tot_Drug_Cst)2024 Drug cost: $4,859,253 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015107705$1,262,194
2016114633$1,228,537
2017106481$1,580,594
201893548$2,114,356
2019183926$3,054,462
20201881,223$3,273,865
20212241,207$2,576,276
20222231,304$3,786,295
20232061,216$3,871,223
20242201,499$4,859,253

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$3.2K$6.4K2015 Medicare payment: $3,589 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $4,682 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $5,546 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $5,837 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $6,409 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $6,230 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $2,703 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R92$3,589
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R94$4,682
2020N/R135$5,546
2021N/R102$5,837
2022N/R115$6,409
2023N/R105$6,230
2024N/R117$2,703

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more3554$105
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more4848$98
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes1319$85
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more146227$69
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more127146$41

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JakafiRuxolitinib Phosphate581,740$983,115
LenalidomideLenalidomide29812$468,032
ImfinziDurvalumab17413$213,946
BrukinsaZanubrutinib15436$208,966
Darzalex FasproDaratumumab-Hyaluronidase-Fihj24623$208,185

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4222Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)NN/R26$1,123
J9190Injection, fluorouracil, 500 mgNN/R25$438
A4221Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)NN/R19$412
J8521Capecitabine, oral, 500 mgNN/R15$358
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R21$251

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.210$122,729E.R. Squibb & Sons, L.L.C.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alexander Barsouk, MD?

Tedicare shows public-source Medicare data for Alexander Barsouk, MD (NPI 1114929544), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander Barsouk, MD have ACO affiliation data?

Alexander Barsouk, MD is shown with ACO affiliation data for Bridges Health Partners Accountable Care Organization (MSSP, ACO ID A3919).

What billing organization is linked to Alexander Barsouk, MD?

Alexander Barsouk, MD is linked to BUTLER MEDICAL PROVIDERS (billing NPI 1639788102) in the available physician profile data.

Does Alexander Barsouk, MD have Open Payments data?

Alexander Barsouk, MD has 210 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.